On Focus

Joining me today is Gemma Harris, a physiotherapist who specialises in helping people regain strength and confidence following a cancer diagnosis and treatment. Before establishing the Wellbeing and Rehab Collective in Surrey where she currently practices, Gemma was part of the exercise medicine team at Genesis Care, an internationally recognised group of cancer care specialists.  She's here today to discuss how Exercise medicine is regarded by many as a key element of cancer recovery and how she works with men who have been diagnosed and treated for prostate cancer.  https://wellbeingandrehabcollective.co.uk/

Joining On Focus today is Dr Francesco Giganti, Associate Professor and honorary Consultant in Radiology at University College London.  Francesco is an acknowledged leader in researching imaging of the prostate, and in identifying new approaches to improve its accuracy in diagnosis and its effectiveness in treatment. He has co-authored over 200 publications reporting on investigations into multiple clinical, technological, and systemic challenges to prostate imaging, and his work has had, and continues to have, profound impact on clinical practice.   He's here today to talk about how MRI has transformed the diagnosis and treatment of prostate cancer,  and what challenges need to be overcome to ensure that this transformational and continually evolving element of the diagnostic pathway is available and accessible to all men. Research publications by Francesco Giganti: https://www.researchgate.net/profile/Francesco-Giganti-2

Elvin Box, a popular and passionate advocate for men with prostate cancer joins this episode of onFocus. Diagnosed in 2016, Elvin is a Movember UK ambassador and has written and campaigned extensively on a number of issues impacting men and their families as they experience a diagnosis of prostate cancer and navigate treatment options. He's here today at the end of Mens Health Week to share his perspective on mens health awareness and how prostate cancer fits into this.  https://uk.movember.com/

Marc Laniado, Consultant Urologist at with The Focal Therapy Clinic and a leading innovator in imaging led diagnostics and targeted treatments for prostate cancer, joins On Focus in this episode. Marc has been a vocal advocate for the rights of patients to be informed about their treatment choices from his base at Frimley Health, where he is prostate cancer lead at Wexham Park Hospital. He's also a dedicated practitioner in optimising treatment choices for patients, and has built a reputation in identifying and delivering the right treatment for each patient, based on precise diagnostics and comprehensive discussion about lifestyle, aspirations and relationships. He's here today to speak about how some recent media attention on Active Surveillance might be interpreted, and what men diagnosed with localised prostate need to know about their treatment choices.  Marc discusses the ProtecT trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2214122

Joining OnFocus today is Oliver Kemp, CEO of Prostate Cancer Research in the UK and Director of PCR inc in the USA, whose missions Oliver describes as “to use our deep understanding of patient priorities and the research ecosystem to enable and implement the innovations that have greatest potential for impact, and to help scientists forge the connections and collaborations which will keep their work at the cutting-edge.” https://www.prostate-cancer-research.org.uk/

Joining OnFocus today is Alan Doherty, Clinical Director at the Birmingham Prostate Clinic, and recently voted one of the UK's top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail. Alan has been an innovator, advocate and dedicated practitioner of precision treatments for prostate cancer, and joined the Focal Therapy Clinic last year to develop his expertise in delivering focal therapy. In addition to HIFU focal therapy, Alan has embraced IRE or NanoKnife focal treatments with great success for his patients, which has reinforced his views on early diagnosis and, in particular, prostate cancer screening. He's here today to speak with me about how advancements in and success with focal therapy change the discussion around screening.

Marc has been a vocal advocate for the rights of patients to be informed about their treatment choices from his base at Frimley Health, where he is prostate cancer lead at Wexham Park Hospital. He's also a dedicated practitioner in optimising treatment choices for patients, and has built a reputation in identifying and delivering the right treatment for each patient, based on precise diagnostics and comprehensive discussion about lifestyle, aspirations and relationships. He's here today to speak with me about a relatively new treatment - IRE focal therapy, also known as the NanoKnife – that he's been offering to patients and how he sees this developing in futureMarc Laniado, Consultant Urologist at with The Focal Therapy Clinic and a leading innovator in imaging led diagnostics and targeted treatments for prostate cancer is today's OnFocus guest.

Brian Bishop joins OnFocus to discuss his experience with NanoKnife treatment for prostate cancer. Brian is 77 and lives in Virginia Water since retiring from a career in the airline industry, and was diagnosed with prostate cancer in May 2022. A few months later he was treated by TFTC Consultant Urologist Marc Laniado with a form of focal therapy that uses electric current to ablate cancerous tissues, also known as the NanoKnife.

Graham Pipe, a recent patient at the Focal Therapy Clinic who underwent HIFU treatment with Consultant Urologist Tim Dudderidge following a diagnosis of localised prostate cancer, joins OnFocus to discuss the process he went through to seek an alternative treatment which would maintain his active lifestyle. Age 70 and recently retired from a career as a Chartered Building Surveyor, Graham describes himself as Young at heart who loves travelling abroad and is married 47 years to the love of his life, who is a model.

This episode's interviewee is Arvin George, Assistant Professor of Urology at the University of Michigan School of Medicine in the USA. A Urologic Surgeon specializing in the diagnosis and management of genitourinary cancers, Professor George's research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer, and he has published widely in these areas. He is also a practicing consulting urologist who has been a leading voice globally on focal therapy and whose contributions to building the evidence base for it have been invaluable to advancing the practice and making focal therapy more accessible to a wider group of patients. Arvin George is here today to share insights from his research and his clinical practice. Arvin George's publications: https://www.researchgate.net/scientific-contributions/Arvin-K-George-2144216305

Consultant Urologist Tim Dudderidge, who works with TFTC and is based at University Hospital Southampton, joins OnFocus today. Tim is an innovator in focal therapy and has coinvestigated most of the clinical trials and studies that have built the evidence base for focal therapy and advanced its adoption and practice. He has recently completed his appointment as Clinical Champion for Prostate Cancer UK, and he's here to discuss what he learned and what implications this might have for patient care.

Joining me today is Almar van Loon, Director of Customer Success at Quantib, a technology company that creates products to support radiologists using artificial intelligence. Almar has a background in clinical radiology, and has worked with Quantib since 2018 as an application specialist supporting radiologists and other clinicians on improving their workflow. One of the products Almar has worked with extensively is Quantib Prostate, which uses AI to read prostate MRI scans, and he's here to discuss how this is impacting clinicians, and ultimately patients, in the diagnosis of prostate cancer. https://www.quantib.com/en/solutions/quantib-prostate

Marc Laniado, Consultant Urologist at The Focal Therapy Clinic and a leading innovator in imaging led diagnostics and targeted treatments for prostate cancer, joins OnFocus to discuss prostate imaging and reporting. Marc has been a dedicated pracititoner and vocal advocate for the rights of patients to be informed about their treatment choices from his base at Frimley Health, where he is prostate cancer lead at Wexham Park Hospital. He's here today to talk about the crucial role that imaging plays in diagnosing and treating prostate cancer, and why a minimal standard of imaging and reporting is essential to successful diagnosis and treatment.

Joining me today is Dr Rafael Sanchez-Salas, an emerging leader in the field of focal therapy for localised prostate cancer. Trained as a urologist in his native Venezuela, Dr Sanchez-Salas led research on robotic surgery and focal therapy for over ten years at the Institut Mutualiste Montsouris Paris, and is now a member of the faculty at McGill University in Montreal where he is leading research on localised prostate cancer and minimally invasive approaches to its management. Dr Sanchez-Salas discusses how the researchers and clinicians in the US and Canada are now deploying the evidence and patient experience gained in the UK and Europe to advance focal therapy.

Joining me today is Chris Lewis, founder and CEO of Chris's Cancer Community, an influential and impactful online community of cancer patients, recoverers, and those affected by cancer. The community has a significant online following (over 35k followers on Twitter) and Chris has shared his unique and substantial knowledge on the daily experience of living with cancer with charities, government organisations and businesses both in the UK and internationally. HE is one of the most knowledgeable, insightful and honest campaigners I've met, and I'm delighted to chat with him today about the current state of cancer services in the UK and what members of his community are telling him about it. https://www.chris-cancercommunity.com @christheeagle1

This episode features Raj Nigam, Consultant Urologist at the Royal Surrey NHS Foundation Trust and the Focal Therapy Clinic. Raj is an andrologist with a special interest in the impact of prostate cancer treatment on sexual and mental health, and has spoken several times with On Focus about age-related implications of prostate cancer treatment. He's here today to discuss a range of issues that have evolved since the pandemic that are impacting how men with localised prostate cancer are being diagnosed and treated. True North project on prostate cancer: https://prostatecanceruk.org/about-us/projects-and-policies/truenth

Joining the podcast today is Alan Doherty, Clinical Director at the Birmingham Prostate Clinic, and recently voted one of the UK's top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail. Alan has been an innovator, advocate and dedicated practitioner of precision treatments for prostate cancer, and joined the Focal Therapy Clinic last year to develop his expertise in delivering focal therapy. Having now treated a large cohort of patients with focal therapy following the Clinic's rigorous MDT review , he's even more positive now about the approach than he's ever been, and joins Clare today to discuss how this experience makes him optimistic about the future of focal therapy and, most importantly, the future for men diagnosed with localised prostate cancer.

Consultant Urologist Tim Dudderidge joins OnFocus to discuss recent trends in technology and research. Tim works with the Focal Therapy Clinic and is based at University Hospital Southampton. He's an innovator in focal therapy and has coinvestigated most of the clinical trials and studies that have built the evidence base for focal therapy and advanced its adoption and practice. Last year he was appointed as Clinical Champion for Prostate Cancer UK, which will give him even more impact on innovative clinical practice across the NHS. In this episode, Tim shares his views on some of the key issues driving practice in diagnosing and treating prostate cancer, and how this is impacting both patients and clinicians.

Joining On Focus today is Grant Evatt, a veteran army commando who now practices law in a firm he founded to specialise in personal injury cases. He has coordinated the Military Special Interest group for the Association of Personal Injury Lawyers (APIL), and is a recognised authority in military claims. He has won millions of pounds for his injured clients and their grieving families and is much liked and respected by them, and his peers, for his exceptional client care and dedication to their cause. Grant's here to speak with me about his experience with prostate cancer and HIFU treatment. Grant Evatt, Alma Law practice https://www.almalaw.co.uk/our-people/grant-evatt

Joining On Focus today is Stuart McIntyre, Director of Marketing & Business Development at AngioDynamics, developer of a new approach to focal therapy called NanoKnife. It is currently running a clinical trial called PRESERVE, described as a Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population and which will evaluate the use of AngioDynamics' NanoKnife System for ablation of prostate tissue as a focal therapy option for prostate cancer patients. Stuart's here to talk about how his company developed the NanoKnife system and what his expectations are for its adoption. PRESERVE trial https://www.angiodynamics.com/announcements/first-patients-treated-in-preserve-clinical-study/

Martin Wells, a campaigner, fundraiser and support group leader from Lancashire, joins On Focus to discuss what it's like going through prostate cancer diagnosis and treatment as a gay man. He set up two support groups to help men and their partners address these challenges - Out with Prostate Cancer and Shaping Prostate Cancer Literacy. Out with Prostate Cancer https://outwithprostatecancer.org.uk/ Shaping Prostate Cancer Literacy https://www.youtube.com/channel/UCjNP3x0ebbh7hbzHcEwudbg

Joining me today is Mish Middelmann, aka “Recovering Man”, the title of the popular blog he produces on his experience with prostate cancer. Mish is an organic veggie gardener, prostate cancer survivor and convenor of the global Recovering Men prostate cancer support group. His blog at www.recoveringman.net very candidly chronicles his own prostate cancer journey and those of others affected by prostate cancer. In his professional life he is a systems coach helping leadership teams and organisations worldwide embrace both change and diversity and inclusiveness. Prior to this he was the co-founder and CEO of a software start-up in Johannesburg, South Africa. He's here to speak with me today about the insights he's gained through his own experience of prostate cancer and working with hundreds of others through his support community.

Today's OnFocus features Michael Hoey, founder of Francis Medical in Minneapolis, Minnesota and a veteran healthcare entrepreneur with a deep passion for helping men with prostate cancer. Prior to establishing Francis Medical in 2018 to focus on new treatments for prostate cancer, Michael co-founded NxThera to develop and commercialize urology applications of a vapor platform technology that he invented. This resulted in the highly successful treatment for non-cancerous prostate disease known as Rezum which is benefitting thousands of men across the world. Michael is a former professor, having taught and led research at the School of Medicine at the University of Minnesota. He joins OnFocus to discuss new approaches to focal therapy and their adoption into medical practice. https://www.francismedical.com/

Dr Art Rastinehad joins On Focus to discuss how focal therapy is being implemented in the US, and how US and UK clinicians and researchers are collaborating to advance its development. Dr Art Rastinehad is Director for Prostate Cancer at the Northwell Health Cancer Institute in New York State and the Vice Chair of Urology at Lenox Hill Hospital in New York City. He trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. He has expertise in a wide array of interventional radiological and surgical techniques, including image-guided procedures, prostate artery embolization, laparoscopic and robotic surgery, and he has authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer, including focal therapy. Recent publication - consensus on moving to Focal therapy Active Surveillance: https://pubmed.ncbi.nlm.nih.gov/33676851/ Dr Art Rastinehad's website: https://drrastinehad.com/

Alphonso Archer joins On Focus in this episode to discuss how his prostate cancer diagnosis changed his life in a very positive way and inspired him to reclaim his passion for music. Alphonso, a former IT sales professional decided, after a prostate cancer diagnosis in 2016, to pursue his lifelong love and passion for music and trained to be a music therapist. He is currently completing a master's degree in music therapy and researching how men with prostate cancer benefit from music therapy for his dissertation. He is also an active member of a support group for black men diagnosed with and recovering from prostate cancer. Alphonso Archer's music: https://open.spotify.com/artist/0p6CGWh3GSj8amuiU7Atsk Alphonso's research: https://uwe.eu.qualtrics.com/jfe/form/SV_4ZufpFVGmJOgBZY

Joining me today is Eva Tomopoulu, a patient advocate with the Focal Therapy Clinic. Eva is the first port of call for patients who approach the clinic, and she has engaged, guided and supported hundreds of men in their journeys to understand their prostate cancer diagnosis and ultimately to choose the optimal treatment for it. She's here to talk about the role of patient advocacy and the benefits it brings to patients and their families. The Focal Therapy Clinic is looking for new patient advocates. If this is of interest to you or someone you know, please get in touch: https://www.thefocaltherapyclinic.co.uk/patient-advocacy-a-critical-asset-for-men-on-the-prostate-cancer-journey/

Joining me today is Raj Nigam, Consultant Urologist at the Royal Surrey County Hospital and the Focal Therapy Clinic. Raj's clinical specialties centre around urological oncology and andrology. He manages men with all andrological conditions including erectile dysfunction, male infertility, Peyronie's disease and male hormonal problems. He also has a major interest in prostate cancer and in particular, precision diagnostics and focal therapies Raj is widely published in national and international journals, and has lectured extensively over the last 20 years. His current research interests are in advanced diagnostics in prostate cancer and the evolution of new treatments to treat prostate conditions. He's here today to address perceptions and misperceptions on personalised medicine –a term that we hear a lot about and which means many things to many people. I've asked him to join me and give his views on what personalised medicine means for diagnosing and treating prostate cancer.

Oliver Hulson, Consultant Radiologist at Leeds NHS Trust and Clinical Champion for Prostate Cancer UK joins OnFocus today to discuss the critical importance of radiology in the diagnosis and treatment of prostate cancer, and what he's doing to both advance imaging effectiveness and instill these advances in clinical practice.

Joining me today is Errol McKellar, founder of the Errol McKellar Foundation which is dedicated to raising awareness of men's health and in particular prostate cancer in the black community. Errol has a legendary status in the London youth football community, having been a coach and scout for over 50 years and supporting the rise of premiership and England players Beckham, Cole and Campbell. His car repair garage in Hoxton has also become legendary – featuring in a documentary on his community now on Amazon prime and most impactfully as an information channel to black men about their health, and it's this latter point that brings Errol to talk with me today. Errol was diagnosed with prostate cancer in 2010 and since then has dedicated himselt to informing & supporting men especially those in the black community about prostate cancer and, in particular, the importance of getting screened. He's been highly recognised for his services. Errol is one of Prostate Cancer UK's main ambassadors and, along with Linford Christie, David Haye, Danny John-Jules, Viv Anderson, Chuka Umunna and Benjamin Zephaniah is fronting their Stronger Knowing More campaign, which encourages black men to get PSA tests. In 2012 Errol was chosen to be one of the Olympic torch bearers in Hackney and in 2016 his volunteer work in the community was recognised by the Prime Minister when he was presented with a Points of Light Award. In 2018 Errol set up and launched The Errol McKellar Foundation and was invited to 10 Downing Street to talk to the Prime Minister, Secretary of State for Health and the Head of NHS England about the prostate cancer awareness work his new charity will undertake. In 2018 Errol was awarded a NHS Heroes Award for his services to volunteering, and in October 2020, he was awarded an MBE for services to raising the awareness of Prostate Cancer. Errol McKellar Foundation https://www.theerrolmckellarfoundation.com/ The Street https://www.imdb.com/title/tt10999260/

Joining onFocus today is Marc Laniado, Consultant Urologist at with The Focal Therapy Clinic and a leading innovator in imaging led diagnostics and targeted treatments for prostate cancer. Marc has been a dedicated practitioner and vocal advocate for the rights of patients to be informed about their treatment choices from his base at Frimley Health, where he is prostate cancer lead at Wexham Park Hospital. He's here today to talk with about how patients can be supported in understanding their diagnosis and choice of treatment through decision tools such as Predict Prostate.

Marc Laniado, Consultant Urologist at with The Focal Therapy Clinic and a leading innovator in imaging led diagnostics and targeted treatments for prostate cancer, joins OnFocus to discuss the concept of precision in the diagnosis and treatment of prostate cancer, why it's important and how it's achieved. Marc has been a dedicated pracititoner and vocal advocate for the precision diagnostics that support focal therapy from his base at Frimley Health, where he is prostate cancer lead at Wexham Park Hospital and has contributed to several pivotal clinical studies and trials on prostate imaging , diagnostics and focal therapy.

Michael Anthony is a recent HIFU patient at the Focal Therapy Clinic, who had just turned 50 late last year when he was diagnosed with localised prostate cancer, quickly followed by a bout with Covid. As he says "I got cancer for my birthday and Covid for Christmas" – and his ultimate treatment was a direct outcome of these memorable “gifts” . He joins OnFocus to tell his story about managing a prostate cancer diagnosis in the Covid era and to share his learnings from this experience with our listeners.

Joining me today is Elvin Box, a popular and passionate advocate for men with prostate cancer. Diagnosed in 2016, Elvin is a Movember UK ambassador and has written and campaigned extensively on a number of issues impacting men and their families as they experience a diagnosis of prostate cancer and navigate treatment options. He's here today to discuss the Movember campaign which begins next week and his mission to eradicate the taboos faced by men with prostate cancer. Movember UK https://uk.movember.com

Robin Pritchard, founder of Cancer Care Map, joins On Focus to discuss how the online map he provides works and how it is impacting the communities it serves. Cancer Care Map was designed to help people living with cancer find care and support services in their local area, anywhere in the UK. These services are wide-ranging and include counselling & support, exercise & fitness and financial advice amongst many others. Its aim is to make sure that no one goes unsupported because they are not aware of a service in their local area. https://www.cancercaremap.org/

Charlie LeBosquet, clinical application specialist for Prostate Care Limited, joins the podcast to discuss his views from the frontline of prostate cancer diagnostics and treatment. Charlie has been a critical link in the theatres where men are biopsied and treated for prostate cancer for nearly two decades, supporting clinicians and operational staff alike, and he has a unique and valuable perspective on the advance and adoption of technology in the diagnosis and treatment of prostate cancer.

Raj Nigam, Consultant Urologist at the Royal Surrey NHS Foundation Trust and the Focal Therapy Clinic is an andrologist with a special interest in the impact of prostate cancer treatment on sexual and mental health, and has spoken several times before on the podcast about age-related implications of prostate cancer treatment. He's here today to discuss how advances in ageing research could potentially aid in recovery from prostate cancer and its treatment. Or, another words, if the biggest risk factor in developing prostate cancer is ageing, what can we do to mitigate that risk?

In our conversation today, he'll comment on some of his experiences with prostate cancer by drawing on passages in his books “Nothing's so bad that it couldn't be worse” and “Taking the piss out of cancer" . You're in for a treat.Today's guest is Raymond Poole from Co Wicklow in Ireland, who is both campaigner and advocate for better treatment and more honest discussion about the impact of prostate cancer on mens' lives. Following his prostate cancer diagnosis and subsequent treatment, he has used both poetry and prose to express his emotions, communicate his experience with honesty and humour, and inspire others to develop their voice and make better choices about their prostate cancer support and treatment. He's Irish, so that may not come as a surprise. Follow Ray on Twitter: @Aladinsane40 Taking the Piss out of Cancer: https://www.raymondpoole.com/taking-the-pi55-out-of-cancer Nothing's so Bad that it Couldn't be Worse https://www.raymondpoole.com/nothing-so-bad-that-it-couldnt-be-worse

Joining me today is Dr Stephen Allan, a retired consultant anaesthetist and former prostate cancer patient. Stephen has a unique perspective on how men are diagnosed and treated for prostate cancer, and shares his wisdom and experience regularly through Tackle Prostate Cancer as a patient representative, and as an advisor to NICE and the National Prostate Cancer Audit.

Joining OnFocus in this episode is Nigel Harris, a medical sales professional from Winchester who recently underwent HIFU treatment with Tim Dudderidge. He leads a very active sporting life, particularly on the ice where he both plays and coaches ice hockey – and following his prostate cancer diagnosis was intent on finding a treatment that wouldn't compromise his lifestyle. As he describes as his personal motto, “ here's still much to do and see”. He's joined me to discuss his experience.

Joining On Focus in this episode to discuss prostate cancer screening, NHS data sharing and maintaining wellness is GP and Men's Health specialist Dr Jeff Foster. Dr Jeff is the author of Man Alive in which he examines the most commonly misunderstood aspects of men's health. His expertise on testosterone deficiency, erectile dysfunction, prostate health, cardiovascular disease and nutrition & wellness has been shared widely through media and applied in his clinical practice.

Joining me today is Alan Doherty, Clinical Director at the Birmingham Prostate Clinic, and recently voted one of the UK's top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail. Alan has been an innovator, advocate and dedicated practitioner of precision treatments for prostate cancer, and joined the Focal Therapy Clinic last year to develop his expertise in delivering focal therapy. He's here today to talk with me about what he's learned in the last year and how he sees the fire of focal therapy from both a provider and patient point of view.

Joining this episode of OnFocus is patient advocate & educator Andrew Gabriel, who through his own experience with prostate cancer and his advocacy work has become a well-known leader of patient support groups and a recognised source of knowledge on hormone therapy. His hugely popular talk Surviving Hormone Therapy has been attended by hundreds of patients and clinicians who value its honesty and candour. Andrew is part of Prostate Cancer UK's Patients as Educators Programme, which support clinicians in their patient engagement. Links to Andrew's videos: https://www.youtube.com/watch?v=soAzPAmhG50 https://www.youtube.com/watch?v=zAtYQZ_lT3s

TFTC Urological Consultant Tim Dudderidge, based at University Hospital Southampton, joins On Focus to discuss some of the new technologies that are coming through that we can expect to see impacting the experience and outcomes for men with prostate cancer. Tim is an innovator in focal therapy and has coinvestigated most of the clinical trials and studies that have built the evidence base for focal therapy and advanced its adoption and practice. He has recently been appointed as Clinical Champion for Prostate Cancer UK, which will give him even more impact on innovative clinical practice across the NHS.

Kirsty Rowlinson-Groves, an exercise specialist who supports men with prostate cancer in preparing for and recovering from treatment, joins On Focus to how men can benefit from programmes like the one she runs in Manchester called Prehab4Cancer This is an exercise, nutrition and wellbeing scheme run through the NHS in Greater Manchester, and has won numerous awards for its dedication, commitment and innovative approach to cancer patients across the region.

Simon Lord, personal trainer and cancer rehab specialist, is also a prostate cancer survivor having had successful robotic surgery in 2010. He joins On Focus to discuss the changes and developments he's observed in diagnostics and treatments for men with prostate cancer and how this impacts the experience of men he works with.

Marcus McKenzie, a teacher from South London who recently underwent prostate surgery after two years spent on Active Surveillance, joins OnFocus to discuss the heightened risk of prostate cancer that black and mixed race men face, how this impacted his experience and what all black and mixed race need to know about managing their prostate health.

TFTC patient Ian Paul joins On Focus to discuss how even the best care can go wrong and what he's learned from his experience seeking a second opinion,

Michael Clay came to the Focal Therapy Clinic after having been placed on Active Surveillance at Torbay Hospital in South Devon. Michael's a 76-year-old retired banker who leads a very active life with his wife and family which, despite his early-stage cancer diagnosis, was being severely compromised by his treatment. He encountered several issues which he feels are very important for all men to hear and understand before they make decisions about treatment for prostate cancer, and he's joined On Focus to discuss these.

Professor Gordon Wishart joins On Focus to discuss the backlog of cancer referrals, diagnoses and treatments in the NHS and offer some suggestions on ways forward. Professor Wishart is founder, Chief Medical Officer and CEO of Check4Cancer, a leading early cancer detection and cancer prevention organisation. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, Professor Wishart has a strong track record in clinical research and modernisation of cancer diagnosis and treatment, with more than 100 peer-reviewed papers in scientific journals. In 2010 he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, now used worldwide. https://www.check4cancer.com

Dr Michael Sagner, bestselling author of Lifestyle Medicine and a pioneer in preventative healthcare, joins OnFocus to discuss the changing narrative around ageing and outlines that by focusing on prevention, personalisation, prediction and participation men can impact their experiences with prostate cancer https://www.amazon.co.uk/Lifestyle-Medicine-Environment-Preventive-Disease-ebook/dp/B06XSJ4ST9

Founder and CEO of PxHealth Anne Bruinvels joins OnFocus to discuss the launch of OWise Prostate, a digital app designed to support men with prostate cancer. https://owise.uk/prostate/